Cromolyn
Active ingredient · 5 therapeutic classes
- Drug class
- Antiallergic Agents, Excl. Corticosteroids
- Availability
- Prescription only
- Routes
- Ophthalmic, Respiratory (Inhalation)
- Markets covered
- 2
- Products on record
- 4
Overview
Cromolyn is an active pharmaceutical ingredient in the Antiallergic Agents, Excl. Corticosteroids group (A07EB). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 3 | April 1, 2026 |
| CA Canada | Health Canada | 1 | March 22, 2025 |
USUnited States· FDA
3 products
Uses
Indications and Usage Cromolyn sodium inhalation solution USP is a prophylactic agent indicated in the management of patients with bronchial asthma. In patients whose symptoms are sufficiently frequent to require a continuous program of medication, cromolyn sodium inhalation solution USP is given by inhalation on a regular daily basis (see DOSAGE AND ADMINISTRATION ).
The effect of cromolyn sodium is usually evident after several weeks of treatment, although some patients show an almost immediate response. , cromolyn sodium should be given shortly before exposure to the precipitating factor (see DOSAGE AND ADMINISTRATION ).
How to take
CACanada· Health Canada
1 product
Uses
) . 1 Pediatrics Pediatrics (from 5 to 18 years of age): Based on the data submitted and reviewed by Health Canada, the safety and efficacy of CROMOLYN EYE DROPS in pediatric patients has been established. Therefore, Health Canada has authorized an indication for pediatric use.
) See 4 DOSAGE AND ADMINISTRATION. 2 Geriatrics Geriatrics (over 65 years of age): No data are available to Health Canada; therefore, Health Canada has not authorized an indication for geriatric use.
How to take
Sources & citations
- [1]FDA DailyMed · 0209cd6c-5c43-0b… · revised December 10, 2025 [PDF]
- [2]Health Canada (DPD) · 02009277 · revised March 22, 2025
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.